Document Detail


Modulation of advanced glycation end products by candesartan in patients with diabetic kidney disease--a dose-response relationship study.
MedLine Citation:
PMID:  19829095     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Advanced glycation end products (AGEs) are proinflammatory mediators implicated in the pathogenesis of diabetic kidney disease (DKD). In this study, dose-dependent effects of angiotensin receptor blockade on urinary AGEs were evaluated in patients with DKD. Patients with type 2 diabetes and proteinuria ≥500 mg/d (n = 11) were compared with diabetic controls without DKD (n = 10) and normal controls (n = 11). After a 2-week washout period, DKD participants were treated with candesartan doses progressively increasing from 8, 16, 32, to 64 mg/d every 3 weeks for a total of 12 weeks. Other antihypertensive agents were adjusted to maintain stable blood pressure. At baseline and after each dosing period, blood pressure measurements and 24-hour urine collections were obtained. Urinary carboxymethyl lysine, an AGE biomarker, was reduced over the 12-week dose escalation protocol (r = 0.38, P = 0.01) in DKD participants. Creatinine clearance increased slightly, but albuminuria was unaffected by candesartan administration. Baseline urinary transforming growth factor-β₁ excretion was lower in DKD participants than in controls and did not change during the study period. Reducing kidney exposure to AGEs may be a mechanism of protection by angiotensin receptor blockade in DKD. AGEs may also impact the diabetic kidney through mechanisms independent of transforming growth factor-β₁.
Authors:
Sandeep A Saha; Brian K LaSalle; G Dennis Clifton; Robert A Short; Katherine R Tuttle
Related Documents :
9377725 - Renal effects of insulin in man.
1462865 - The kallikrein-kinin system in early state of diabetes.
10615955 - Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationsh...
8875095 - Erythrocyte sodium-hydrogen exchange and microalbuminuria in type i diabetes.
16873135 - Relationship between bmi, total testosterone, sex hormone-binding-globulin, leptin, ins...
11168335 - Near-normoglycaemic remission in african-americans with type 2 diabetes mellitus is ass...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of therapeutics     Volume:  17     ISSN:  1536-3686     ISO Abbreviation:  Am J Ther     Publication Date:    2010 Nov-Dec
Date Detail:
Created Date:  2010-11-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9441347     Medline TA:  Am J Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  553-8     Citation Subset:  IM    
Affiliation:
Providence Medical Research Center, Sacred Heart Medical Center, Spokane, WA 99204, USA. sahas@u.washington.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Therapeutic Challenges in Combined Apical Ballooning Syndrome and Acute Pulmonary Decompensation.
Next Document:  A selected controlled trial of supplementary vitamin e for treatment of muscle cramps in hemodialysi...